Viemed Healthcare, INC Form 4 insider transactions
NASDAQ
Director Timothy Smokoff exercised stock options to acquire 10,719 common shares of Viemed Healthcare on August 25, 2024.
NASDAQ
Director Randy E. Dobbs exercised 12,611 Restricted Stock Units (RSUs) of Viemed Healthcare, Inc. on August 25, 2024, converting them into common shares.
NASDAQ
Chief Medical Officer William Frazier reports the vesting of restricted stock units and subsequent tax withholding of shares.
NASDAQ
Nitin Kaushal, a director at Viemed Healthcare, exercised stock options on August 25, 2024, acquiring 10,719 common shares.
NASDAQ
General Counsel Jeremy Trahan reports the vesting and disposal of phantom shares and restricted stock units in Viemed Healthcare.
NASDAQ
Bruce D. Greenstein, a director of Viemed Healthcare, was granted 15,732 Restricted Stock Units (RSUs) on August 20, 2024, which vest on August 20, 2025.
NASDAQ
Director Nitin Kaushal received 15,732 Restricted Stock Units (RSUs) in Viemed Healthcare, Inc. on August 20, 2024, which vest on August 20, 2025.
NASDAQ
Director Randy E. Dobbs received 17,784 Restricted Stock Units (RSUs) in Viemed Healthcare, Inc. on August 20, 2024, which vest on August 20, 2025.
NASDAQ
Director Timothy Smokoff received 15,732 Restricted Stock Units (RSUs) from Viemed Healthcare, vesting on August 20, 2025.
NASDAQ
Director Sabrina Heltz reports acquisition of 15,732 Restricted Stock Units in Viemed Healthcare, Inc.
NASDAQ
Director Sabrina Heltz recently purchased additional shares of Viemed Healthcare, increasing her direct holdings in the company.
NASDAQ
Trae Fitzgerald, CFO of Viemed Healthcare, reports the vesting and settlement of phantom share units, resulting in a change in beneficial ownership of company stock.
NASDAQ
William Todd Zehnder, Chief Operating Officer of Viemed Healthcare, reports the vesting and settlement of phantom share units.
NASDAQ
Michael Moore, President of Viemed Healthcare, reports the vesting and settlement of phantom share units, resulting in changes to his beneficial ownership.
NASDAQ
Jerome Cambre, Vice President of Sales at Viemed Healthcare, reported the vesting and settlement of phantom share units on May 9, 2024.
NASDAQ
CEO Hoyt Casey reports the vesting and settlement of phantom share units, resulting in changes to his beneficial ownership of Viemed Healthcare stock.
NASDAQ
Viemed Healthcare's CEO, Casey Hoyt, donated 26,000 common shares to a charity on March 22, 2024.